Antimetische Therapie 11. Prophylaxe und Therapie Zytostatika-induzierten Erbrechens

[1]  G. Plosker,et al.  Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic. , 1993, Drugs.

[2]  E. Warner,et al.  Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil. , 1993, The New England journal of medicine.

[3]  V. Kataja,et al.  5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised study. , 1993, European journal of cancer.

[4]  J. Hainsworth,et al.  Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  B. Costall,et al.  Neuropharmacology of emesis in relation to clinical response. , 1992, The British journal of cancer. Supplement.

[6]  M. Kris,et al.  Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis. , 1992, Cancer.

[7]  Liège,et al.  Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetron Study Group. , 1992, British Journal of Cancer.

[8]  A. Favero,et al.  Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis , 1992 .

[9]  K. M. Bruijn.  Tropisetron. A review of the clinical experience. , 1992 .

[10]  V. Kataja,et al.  Ondansetron and tropisetron with dexamethasone in the prophylaxis of acute vomiting induced by non-cisplatin-containing chemotherapy. , 1992, Acta oncologica.

[11]  D. Christmann,et al.  Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. , 1991, European journal of cancer.

[12]  E. Newlands,et al.  Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy , 1991, The Lancet.

[13]  G. Hortobagyi,et al.  Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Milne,et al.  Ondansetron , 2012, Drugs.

[15]  B. Lebeau,et al.  Efficacité antiémétique de l'ondansétron : comparaison randomisée avec l'association alizapride-méthylprednisolone dans les cancers bronchiques traités par cisplatine , 1991 .

[16]  M. Tonato,et al.  Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis. , 1991, European journal of cancer.

[17]  C. Seynaeve,et al.  Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study. , 1990, Annals of internal medicine.

[18]  J. Bonneterre,et al.  A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  S. Kaasa,et al.  A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. International Emesis Study Group. , 1990, European journal of cancer.

[20]  D. Giannarelli,et al.  Effective Control of CMF‐Related Emesis with High‐Dose Dexamethasone: Results of a Double‐Blind Crossover Trial with Metoclopramide and Placebo , 1989, American journal of clinical oncology.

[21]  C. Lindley,et al.  Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  S. Groshen,et al.  Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  A. Favero,et al.  A Double‐Blind Trial Comparing Antiemetic Efficacy and Toxicity of Metoclopramide Versus Methylprednisolone Versus Domperidone in Patients Receiving Doxorubicin Chemotherapy Alone or in Combination with Other Antiblastic Agents , 1988, American journal of clinical oncology.

[24]  M. Tonato,et al.  Methylprednisolone versus metoclopramide for prevention of nausea and vomiting in breast cancer patients treated with intravenous cyclophosphamide methotrexate 5-fluorouracil: a double-blind randomized study. , 1988, Oncology.

[25]  S. Groshen,et al.  Antiemetic control and prevention of side effects of anti‐cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double‐blind, randomized trial , 1987, Cancer.

[26]  P. Bruzzi,et al.  Methylprednisolone for the Control of CMF‐Induced Emesis , 1987, American journal of clinical oncology.

[27]  R. Joss,et al.  The antiemetic activity of high‐dose alizapride and high‐dose metoclopramide in patients receiving cancer chemotherapy: A prospective, randomized, double‐blind trial , 1986, Clinical pharmacology and therapeutics.

[28]  R. Saller,et al.  Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis. , 1985, Cancer treatment reports.

[29]  S. Groshen,et al.  Improved control of cisplatin‐induced emesis with high‐dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients , 1985, Cancer.

[30]  D. Ettinger,et al.  Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. , 1984, The New England journal of medicine.